Tularemia pathophysiology: Difference between revisions

Jump to navigation Jump to search
Line 5: Line 5:


==Pathophysiology==
==Pathophysiology==
Tularemia is caused by the bacterium ''Francisella tularensis'' found in animals (especially rodents, rabbits, and hares). ''Francisella tularensis'' (''F. tularensis'') is a tiny, pleomorphic, nonmotile, [[gram-negative]], facultative intracellular coccobacillus (0.2 to 0.5 μm by 0.7 to 1.0 μm). It is a fastidious organism and may require cysteine supplementation for good growth on general laboratory media.
*''F. tularensis'' can infect humans through the [[skin]], [[mucous membranes]], [[gastrointestinal tract]], and [[lungs]]. It is a facultative intracellular bacterium that multiplies within macrophages. The major target organs are the [[lymph nodes]], [[lungs]] and [[pleura]], [[spleen]], [[liver]], and [[kidney]]. Untreated, bacilli inoculated into skin or mucous membranes multiply, spread to regional lymph nodes and further multiply, and then may disseminate to organs throughout the body.
*[[Bacteremia]] may be common in the early phase of infection. The initial tissue reaction to infection is a focal, intensely suppurative [[necrosis]] consisting largely of accumulations of polymorphonuclear [[leukocyte]]s, followed by invasion of [[macrophage]]s, [[epithelioid]] cells, and [[lymphocytes]].
*Suppurative lesions become [[granulomatous]], and [[histopathological]] examination of the [[granulomas]] shows a central necrotic, sometimes caseating, zone surrounded by a layer of epithelioid cells, [[multinucleated giant cell]]s, and [[fibroblast]]s in a radial arrangement, typical of other granulomatous conditions such as [[tuberculosis]] and [[sarcoidosis]].
*Humans with inhalational exposures also develop hemorrhagic [[inflammation]] of the airways early in the course of illness, which may progress to [[bronchopneumonia]]. Histopathological examination of the lungs shows alveolar spaces filled with an exudate of mononuclear cells. [[Pleuritis]] with adhesions and effusion and [[hilar]] [[lymphadenopathy]] are common in radiological and pathological findings.
*Primary clinical forms vary in severity and presentation according to virulence of the infecting organism, dose, and site of inoculum.
*The onset of tularemia is usually abrupt, with [[fever]] (38oC–40oC), [[headache]], [[chills]] and rigors, generalized body aches (often prominent in the low back), [[coryza]], and sore throat. A pulse-temperature dissociation has been noted in as many as 42% of patients. A dry or slightly productive cough and substernal pain or tightness frequently occur with or without objective signs of [[pneumonia]], such as purulent sputum, [[dyspnea]], [[tachypnea]], pleuritic pain, or [[hemoptysis]]. [[Nausea]], [[vomiting]], and [[diarrhea]] may occur.
*Sweats, [[fever]], [[chills]], progressive weakness, [[malaise]], [[anorexia]], and [[weight loss]] characterize the continuing illness.
*In general, tularemia would be expected to have a slower progression of illness and a lower case-fatality rate than either inhalational [[plague]] or [[anthrax]]. Milder forms of inhalational tularemia would be indistinguishable from [[Q fever]]; another potential bioterrorism agent; establishing a diagnosis of either would be problematic without reference laboratory testing.<ref>http://www.bt.cdc.gov/agent/tularemia/facts.asp</ref><ref>http://www.asm.org/ASM/files/LEFTMARGINHEADERLIST/DOWNLOADFILENAME/0000000525/tularemiaprotocol%5B1%5D.pdf</ref><ref>http://www.bt.cdc.gov/agent/tularemia/tularemia-biological-weapon-abstract.asp#2
</ref>
==References==
==References==
{{reflist|2}}
{{reflist|2}}

Revision as of 21:35, 10 December 2012

Tularemia Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Tularemia from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Other Diagnostic Findings

Treatment

Medical Therapy

Prevention

Case Studies

Case #1

Tularemia pathophysiology On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Tularemia pathophysiology

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Tularemia pathophysiology

CDC on Tularemia pathophysiology

Tularemia pathophysiology in the news

Blogs on Tularemia pathophysiology

Directions to Hospitals Treating Tularemia

Risk calculators and risk factors for Tularemia pathophysiology

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Pathophysiology

Tularemia is caused by the bacterium Francisella tularensis found in animals (especially rodents, rabbits, and hares). Francisella tularensis (F. tularensis) is a tiny, pleomorphic, nonmotile, gram-negative, facultative intracellular coccobacillus (0.2 to 0.5 μm by 0.7 to 1.0 μm). It is a fastidious organism and may require cysteine supplementation for good growth on general laboratory media.

  • F. tularensis can infect humans through the skin, mucous membranes, gastrointestinal tract, and lungs. It is a facultative intracellular bacterium that multiplies within macrophages. The major target organs are the lymph nodes, lungs and pleura, spleen, liver, and kidney. Untreated, bacilli inoculated into skin or mucous membranes multiply, spread to regional lymph nodes and further multiply, and then may disseminate to organs throughout the body.
  • Bacteremia may be common in the early phase of infection. The initial tissue reaction to infection is a focal, intensely suppurative necrosis consisting largely of accumulations of polymorphonuclear leukocytes, followed by invasion of macrophages, epithelioid cells, and lymphocytes.
  • Suppurative lesions become granulomatous, and histopathological examination of the granulomas shows a central necrotic, sometimes caseating, zone surrounded by a layer of epithelioid cells, multinucleated giant cells, and fibroblasts in a radial arrangement, typical of other granulomatous conditions such as tuberculosis and sarcoidosis.
  • Humans with inhalational exposures also develop hemorrhagic inflammation of the airways early in the course of illness, which may progress to bronchopneumonia. Histopathological examination of the lungs shows alveolar spaces filled with an exudate of mononuclear cells. Pleuritis with adhesions and effusion and hilar lymphadenopathy are common in radiological and pathological findings.
  • Primary clinical forms vary in severity and presentation according to virulence of the infecting organism, dose, and site of inoculum.
  • The onset of tularemia is usually abrupt, with fever (38oC–40oC), headache, chills and rigors, generalized body aches (often prominent in the low back), coryza, and sore throat. A pulse-temperature dissociation has been noted in as many as 42% of patients. A dry or slightly productive cough and substernal pain or tightness frequently occur with or without objective signs of pneumonia, such as purulent sputum, dyspnea, tachypnea, pleuritic pain, or hemoptysis. Nausea, vomiting, and diarrhea may occur.
  • Sweats, fever, chills, progressive weakness, malaise, anorexia, and weight loss characterize the continuing illness.
  • In general, tularemia would be expected to have a slower progression of illness and a lower case-fatality rate than either inhalational plague or anthrax. Milder forms of inhalational tularemia would be indistinguishable from Q fever; another potential bioterrorism agent; establishing a diagnosis of either would be problematic without reference laboratory testing.[1][2][3]

References

Template:WH Template:WS